USPSTF: Evidence Lacking for Lipid Disorder Screening in Children
Current evidence is inadequate for assessing the balance of benefits and harms of screening in a pediatric population
Diagnosis & Disease Information
Follow-Up Colonoscopy Rates Low After Positive Stool-Based Test
Follow-up colonoscopy rates were 43.3% within 90 days, 56.1% within 360 days of positive stool-based screening test result
Web-Based System Works Well for Diagnosis, Treatment of Recurrent Vertigo
Recurrent benign paroxysmal positional vertigo resolved for 72.4 percent of patients using web-based system
Risk for Advanced Neoplasm Low 10+ Years After Negative Colonoscopy
Prevalence of advanced neoplasms 40 to 50% lower among those who underwent repeated screening ≥10 years after a negative colonoscopy
FDA Clears Test to Aid in Early Detection of Sepsis
The semi-quantitative test uses a whole blood sample to assess cellular host response by analyzing the biophysical properties of white blood cells.
Nonphysician Practitioners More Likely to Use Contrast Media for CT
1.55 percent difference in utilization rate for CT contrast media between localities with 10 percent different in NPP evaluation and management share
CDC Extends BMI-for-Age Growth Charts to Monitor Severe Obesity in Children, Adolescents
Extended method uses additional data from 1999 to 2016 NHANES, rather than extrapolation; improves characterization of extremely high BMI in children
Certain Detect COVID-19 Tests Recalled Due to Risk of False Negative Results
Detect, Inc. is voluntarily recalling 3 lots of the Detect COVID-19 Test™ due to an increased risk of false negative results. The Detect COVID-19 Test is a molecular, over-the-counter test used to identify SARS-CoV-2 in self-collected nasal swabs. The affected lots (HB264, HY263, and HY264) were distributed to customers from July 26, 2022 to August…
Dexcom G7 Continuous Glucose Monitoring System Gets FDA Clearance
Dexcom G7 offers new features with a 60% smaller, discreet wearable patch.
